Navigation Links
Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
Date:9/5/2007

Keane InSight Product to Enhance Patient Safety, Improve Efficiency

SAN RAMON, Calif., Sept. 5 /PRNewswire/ -- Keane, Inc., a $1 billion-plus global services firm that specializes in enabling transformation of its clients' business and IT functions, today announced that it has been awarded a $1 million software and services contract with Capital Health System, a two- hospital, 619-bed regional health system based in Mercer County, N.J., to install clinical components of its Keane InSight product line.

As part of the implementation, Keane will install its clinical Electronic Medical Record (EMR) and Pharmacy application throughout the facility to provide clinicians with immediate access to patient information using secure, browser-based technology at the point of service.

"Capital Health System provides its patients with more state-of-the-art technology than any other healthcare system in the region," said Gene Grochala, Chief Information Officer at Capital Health System. "We chose Keane's InSight product because of its extensive clinical functionality for physicians and nurses, and feature-rich display capabilities, infrastructure simplification, as well as the ease of integration with our existing IT infrastructure. We were impressed with the high level of experience and dedication of Keane's team, and look forward to working together on this implementation. We remain committed to providing our patients with the best technology available."

"Patient safety is a major concern for healthcare organizations today, and our Keane InSight product line provides clinicians with better access to critical patient information," said Marv Mouchawar, Executive Vice President, Products and Corporate Development. "By bringing complete patient information directly to the point of service, Keane InSight helps improve clinical decision making and minimizes medical errors."

Mr. Mouchawar added, "This deal helps establish Keane as a leader in the Ne
'/>"/>

SOURCE Keane, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Drug May Make Breathing Easier for Millions
2. Hundred million dollar gift for malaria institute
3. George Bush pledges 200 million dollars for AIDS relief
4. Over Six Million HIV Infected People In South Africa- Finds A Survey
5. Hope for 11 million children facing death from illnesses
6. The forgotten epidemic killing millions
7. WHO and UNAIDS unveil plan to get 3 million AIDS patients on treatment by 2005
8. Tanzanian Government Sanctions $20 Million For AIDS Arug
9. Grant of $7 million for Orissa Medical College from Japan
10. Merck to pay $ 253.5 million to Vioxx victim family
11. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...Ind., Aug. 29 /PRNewswire/ -- Conseco Insurance Co...announced the availability of its new,indexed uni... The policy,provides upside potential with downsid...niversal life policy that offers the,opportunity f...m index,credit of 1%. Clients can customize their ...
(Date:8/29/2008)...Va., Aug. 29 /PRNewswire-USNewswire/ -- The Custom...d today the launch of the Endocrine,Daily Briefing...tigious,Endocrine Society., Endocrine Daily Brief...0 Endocrine Society members, medical professionals...betes and osteoporosis. Endocrine Daily,Briefing j...
(Date:8/29/2008)...ates disappointed that Obama failed to address the...- Speaking at the Democratic,National Convention W...ed,for a reinvigorated response to the domestic HI...Presidential nominee Barack Obama, Clinton said,"...ble global leadership in,an area in which I am dee...
(Date:8/29/2008)...ON, Aug. 29 /PRNewswire-USNewswire/ -- The followi...Campaign for Tobacco-Free Kids:, For the second t...d to,withdraw sponsorship and promotion of a conce...rnational criticism for engaging in cigarette,mark...p Morris International has been forced to withdraw...
Breaking Medicine News(10 mins):Health News:ConsecoLifeOptions Launched by Conseco Insurance Company as New Universal Life Product 2Health News:Custom Briefings Announces Launch of Endocrine Daily Briefing 2Health News:Bill Clinton and Other Leaders Call For 'Renewal of Battle Against AIDS' in the United States at Democratic Convention 2Health News:Bill Clinton and Other Leaders Call For 'Renewal of Battle Against AIDS' in the United States at Democratic Convention 3Health News:Philip Morris International Forced to Drop Another Concert Sponsorship; Philippines Health Department Applauded for Taking Action 2
...s suffering from tennis elbow ask them to alter th....// A new study evaluating the muscle firing patte... no bearing on the development of tendonitis. Res...p" on the relationship between the development of ...
...has made public its plan of enforcing a ban on smo...ices, cinemas, factories, pubs, bars and such othe... ban.// But the ban does not include outdoors or p...s in England will be required to put up visible “N...
...ey 2005-06 has revealed the extent of spousal viol... injustice meted out to unmarried women. The surve... f 30 organizations who were involved in accumulat...ment in certain categories. Fred Arnold, Vice-Pres...
... needed, especially into the possible genetic and ... in Bhopal exactly// 22 years ago that killed more... subsequent years. Despite the neurological, horm...he survivors are facing besides the genetic damage...
Other Medicine News:Health News:Tennis Elbow is Not Caused Due to Improperly Sized Tennis Racket Grip 2Health News:Tennis Elbow is Not Caused Due to Improperly Sized Tennis Racket Grip 3Health News:Children of Bhopal Gas Victims Suffer from Deformity 2Health News:Children of Bhopal Gas Victims Suffer from Deformity 3
(Date:8/26/2008)...wswire/ -- Semafore Pharmaceuticals Inc.,presented...geted Therapies,in Cancer in Washington, D.C., ann...se inhibitors that demonstrate significant antican... proprietary molecular scaffold has been developed...ign of pan-PI3 kinase inhibitors,as well as isofor...
(Date:8/26/2008)...nnovative Manufacturing - Has Potential to ..., ROCKVILLE, Md., Aug. 26 /PRNewswire-FirstCall/ ...favorable results from the second stage of,the Pha...uenza virus-like,particle (VLP) vaccine candidate....induced robust neutralizing antibody responses. No...
(Date:8/25/2008)... calls it a ,miracle, LATHAM, N.Y., Aug. 25 /PRN...ided Radiation Therapy program at Community Care P... patients using RapidArc(TM),radiotherapy technolo...dvancement that delivers a highly-precise image-gu...tment in two minutes or less., RapidArc treatment...
(Date:8/22/2008)...Newswire-FirstCall/ -- Human Genome,Sciences, Inc....leted the,enrollment and initial dosing of patient...umumab) in combination with the chemotherapy agent... in advanced non-small cell,lung cancer (NSCLC)., ...416/HGSLOGO ), "There is an urgent medical need ...
Breaking Medicine Technology:Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 2Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 4Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 5Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 6Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 2Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 5National Stem Cell Holding in Final Stage Negotiations for Exclusive Licensing of its Recently Discovered Biomaterial for Anti Aging Applications 1501 1National Stem Cell Holding in Final Stage Negotiations for Exclusive Licensing of its Recently Discovered Biomaterial for Anti Aging Applications 1501 2Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine 28MSI 1436 29 Data from the North American Association for the Study of Obe 658 1Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine 28MSI 1436 29 Data from the North American Association for the Study of Obe 658 2Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine 28MSI 1436 29 Data from the North American Association for the Study of Obe 658 3Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine 28MSI 1436 29 Data from the North American Association for the Study of Obe 658 4Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine 28MSI 1436 29 Data from the North American Association for the Study of Obe 658 5Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine 28MSI 1436 29 Data from the North American Association for the Study of Obe 658 6Scientists discover tiny RNAs play a big role in controlling genes 4578 1Public not so sure personalized medicine 4574 1Public not so sure personalized medicine 4574 2
...serex Tango ophthalmic laser system provides two l...isruptor for posterior capsulotomy and iridotomy. ...ing pulsed 532 nm light. The photodisruptor laser ...ser can be easily selected and treatment by both l...
Thin and smooth jaws, designed to enter trough 3 mm incision, cross action.
Flat handle.
Angled shafts, smooth jaws, polished finish.
Medicine Products: